Viwit Pharmaceuticals Limited successfully completed Health Canada Inspection

In September 2018, Viwit Pharmaceuticals Limited successfully completed the 5-days GMP inspection of Health Canada for its API manufacturing unit located at Tengzhou, Shandong, China.

Any regulatory inspection is a challenge, but always a great opportunity for Viwit to exhibit it’s capabilities. Viwit adheres to be in compliance with the concept of cGMP standards and committed to follow high standard quality management system. Finally, Viwit successfully completed the Health Canada GMP inspection with excellent performance.

With the result of Health Canada inspection, Viwit has achieved another milestone in it’s journey of mission to become a global leading pharmaceutical healthcare company.

Viwit will continue to follow the cGMP standards, each operation procedure and provide more safe and high quality products to the market.